127 related articles for article (PubMed ID: 35940519)
21. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in cytogenetic characterization of multiple myeloma.
Saxe D; Seo EJ; Bergeron MB; Han JY
Int J Lab Hematol; 2019 Feb; 41(1):5-14. PubMed ID: 29971938
[TBL] [Abstract][Full Text] [Related]
23. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
Berry NK; Bain NL; Enjeti AK; Rowlings P
J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
25. [Detection of chromosomal aberrations in multiple myeloma with fluorescence in situ hybridization].
Cao P; Chen F; Cheng Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 37(10):983-9. PubMed ID: 23117450
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.
Gao X; Li C; Zhang R; Yang R; Qu X; Qiu H; Xu J; Lu H; Li J; Chen L
Med Oncol; 2012 Sep; 29(3):2200-6. PubMed ID: 21611837
[TBL] [Abstract][Full Text] [Related]
27. New insights into the biology of multiple myeloma using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level.
Nickenig C; Lang NK; Schoch C; Hiddemann W; Haferlach T
Ann Hematol; 2001 Nov; 80(11):662-8. PubMed ID: 11757725
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.
Ha J; Cho H; Lee TG; Shin S; Chung H; Jang JE; Kim SJ; Cheong JW; Lee ST; Kim JS; Choi JR
Sci Rep; 2022 May; 12(1):8287. PubMed ID: 35585097
[TBL] [Abstract][Full Text] [Related]
29. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent in situ hybridization studies in multiple myeloma.
Yuregir OO; Sahin FI; Yilmaz Z; Kizilkilic E; Karakus S; Ozdogu H
Hematology; 2009 Apr; 14(2):90-4. PubMed ID: 19298720
[TBL] [Abstract][Full Text] [Related]
31. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
[TBL] [Abstract][Full Text] [Related]
32. [Detection of complex chromosomal aberrations in patients with multiple myeloma using multiplex fluorescence in situ hybridization].
Jiang YQ; Chen LJ; Zhu Y; Qiu HR; Wang R; Xu JR; Lu H; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):441-4. PubMed ID: 20677154
[TBL] [Abstract][Full Text] [Related]
33. Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse.
Mlynarcikova M; Balcarkova J; Mickova P; Scudla V; Pika T; Bacovsky J; Minarik J; Janousova E; Jarosova M
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):358-65. PubMed ID: 27052024
[TBL] [Abstract][Full Text] [Related]
34. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
[TBL] [Abstract][Full Text] [Related]
36. Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.
Dalland JC; Smadbeck JB; Sharma N; Meyer RG; Pearce KE; Greipp PT; Peterson JF; Kumar S; Ketterling RP; King RL; Baughn LB
Genes Chromosomes Cancer; 2021 Oct; 60(10):678-686. PubMed ID: 34124820
[TBL] [Abstract][Full Text] [Related]
37. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
González MB; Hernández JM; García JL; Lumbreras E; Castellanos M; Hernández JM; Fernández-Calvo J; Gutiérrez NC; San Miguel JF
Haematologica; 2004 Oct; 89(10):1213-8. PubMed ID: 15477206
[TBL] [Abstract][Full Text] [Related]
38. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
[TBL] [Abstract][Full Text] [Related]
39. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].
An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360
[TBL] [Abstract][Full Text] [Related]
40. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
